• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

睾丸癌的生育力保存-生精预测因素。

Fertility preservation in testicular cancer - predictors of spermatogenesis.

机构信息

GKT School of Medical Education, King's College London, London, UK.

College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.

出版信息

BJU Int. 2018 Aug;122(2):236-242. doi: 10.1111/bju.14214. Epub 2018 Apr 17.

DOI:10.1111/bju.14214
PMID:29667332
Abstract

OBJECTIVES

To determine the frequency of spermatogenesis in patients with testicular cancer and to assess for any predictors of spermatogenesis.

PATIENTS AND METHODS

We retrospectively reviewed 103 testicular germ cell tumours (TGCTs) in men who underwent radical orchidectomy conducted at Guy's Hospital, London, between 2011 and 2015. Primary outcome measures included: the presence and characteristics of spermatogenesis (widespread/focal/proximity to tumour). Secondary outcome measures included: the presence of testicular microlithiasis, tumour characteristics (size, stage, and type), and tumour markers. Secondary outcome measures as potential predictors of spermatogenesis were assessed using univariate and multivariate logistic regression analyses.

RESULTS

Spermatogenesis was present in 70% (72/103) of the patients; it was widespread in 63% (45/72) and focal in 38% (27/72). Neither tumour type, stage, presence of microcalcification nor tumour markers predicted spermatogenesis. Men with a percentage testis tumour occupation (PTTO) of >50% of their testis were 82% (95% confidence interval 73.2-98.4) less likely to have spermatogenesis than a PTTO of <50%.

CONCLUSIONS

Spermatogenesis is present in most testes affected by TGCTs; it is widespread in two-thirds of patients, and located away from the tumour in 94%. These findings can help predict and guide successful surgical sperm retrieval in testes with TGCTs. The finding of focal spermatogenesis in a third of patients would support a microsurgical approach to sperm retrieval at the time of orchidectomy to maximise success.

摘要

目的

确定睾丸生殖细胞肿瘤(TGCT)患者的生精频率,并评估生精的任何预测因素。

患者和方法

我们回顾性分析了 2011 年至 2015 年期间在伦敦盖伊医院接受根治性睾丸切除术的 103 例男性 TGCT 患者。主要结局指标包括:生精的存在和特征(广泛/局灶/靠近肿瘤)。次要结局指标包括:睾丸微石症、肿瘤特征(大小、分期和类型)和肿瘤标志物。使用单变量和多变量逻辑回归分析评估了作为生精潜在预测因素的次要结局指标。

结果

70%(72/103)的患者存在生精;63%(45/72)为广泛型,38%(27/72)为局灶型。肿瘤类型、分期、微钙化的存在或肿瘤标志物均不能预测生精。睾丸肿瘤占位百分比(PTTO)>50%的男性生精的可能性比 PTTO<50%的男性低 82%(95%置信区间 73.2-98.4)。

结论

大多数患有 TGCT 的睾丸都存在生精;三分之二的患者为生精广泛型,且 94%的生精远离肿瘤。这些发现可以帮助预测和指导 TGCT 睾丸中成功的手术精子获取。三分之一患者存在局灶性生精,这支持在睾丸切除术时采用微创手术方法以最大限度提高成功率。

相似文献

1
Fertility preservation in testicular cancer - predictors of spermatogenesis.睾丸癌的生育力保存-生精预测因素。
BJU Int. 2018 Aug;122(2):236-242. doi: 10.1111/bju.14214. Epub 2018 Apr 17.
2
Spermatogenesis in tumor-bearing testes in germ cell testicular cancer patients.生殖细胞睾丸癌患者荷瘤睾丸中的精子发生
Hum Reprod. 2015 Dec;30(12):2853-8. doi: 10.1093/humrep/dev250. Epub 2015 Oct 1.
3
Predictors of spermatogenesis in orchiectomy specimens.睾丸切除术标本中精子发生的预测因素。
Urology. 2013 Feb;81(2):288-92. doi: 10.1016/j.urology.2012.10.038.
4
Predictors of spermatogenesis in radical orchiectomy specimen and potential implications for patients with testicular cancer.根治性睾丸切除术标本中精子发生的预测因子及其对睾丸癌患者的潜在影响。
Fertil Steril. 2016 Jul;106(1):70-74. doi: 10.1016/j.fertnstert.2016.03.012. Epub 2016 Mar 19.
5
Spermatogenesis in the contralateral testis of patients with testicular germ cell cancer: histological evaluation of testicular biopsies and a comparison with healthy males.睾丸生殖细胞癌患者对侧睾丸的精子发生:睾丸活检的组织学评估及与健康男性的比较
BJU Int. 2007 May;99(5):1079-85. doi: 10.1111/j.1464-410X.2006.06686.x. Epub 2007 Jan 22.
6
Using microscope for onco-testicular sperm extraction for bilateral testis tumors.使用显微镜进行肿瘤睾丸精子提取术治疗双侧睾丸肿瘤。
Fertil Steril. 2018 Apr;109(4):745. doi: 10.1016/j.fertnstert.2018.01.016.
7
Risk for testicular germ cell tumors and spermatogenesis failure in post-pubertal undescended testes.隐睾症患者青春期后发生睾丸生殖细胞肿瘤和精子发生衰竭的风险。
Int Urol Nephrol. 2024 Jul;56(7):2269-2274. doi: 10.1007/s11255-024-03963-4. Epub 2024 Feb 13.
8
The Status of Spermatogenesis in Germ Cell Tumor Bearing Testis and Its Association with Metastatic Disease.精原细胞瘤患者睾丸中精子发生的状态及其与转移疾病的关系。
Clin Genitourin Cancer. 2024 Jun;22(3):102089. doi: 10.1016/j.clgc.2024.102089. Epub 2024 Apr 4.
9
A rare case of bilateral synchronous spermatocytic tumours in a young man seeking fertility preservation.一名寻求保留生育能力的年轻男性发生双侧同步精母细胞瘤的罕见病例。
Scand J Urol. 2017 Feb;51(1):78-80. doi: 10.1080/21681805.2016.1249515. Epub 2016 Nov 4.
10
[Focal surgery in testis cancer: current state of the art].[睾丸癌的局部手术:当前技术水平]
Urologia. 2013 Sep-Dec;80(4):290-6. doi: 10.5301/RU.2013.11687. Epub 2013 Dec 16.

引用本文的文献

1
Preserving Reproductive Potential in the Solitary Testis With Germ Cell Tumour and Azoospermia Using Onco-Testicular Sperm Extraction (TESE): A Case Report.使用肿瘤睾丸精子提取术(TESE)保留患有生殖细胞肿瘤和无精子症的单侧睾丸的生殖潜能:一例报告
Cureus. 2025 Mar 20;17(3):e80919. doi: 10.7759/cureus.80919. eCollection 2025 Mar.
2
Oncological microdissection testicular sperm extraction (Onco-microTESE) outcomes for fertility preservation of patients with testicular cancer with azoospermia or severe oligoasthenoteratozoospermia.用于患有无精子症或严重少弱畸精子症的睾丸癌患者生育力保存的肿瘤学显微解剖睾丸精子提取(Onco - microTESE)结果
BJU Int. 2025 Feb;135(2):295-302. doi: 10.1111/bju.16553. Epub 2024 Nov 16.
3
Knowledge and intentions to use fertility preservation among urban Chinese cancer patients: A study from Hong Kong.
香港地区城市癌症患者对生育力保存知识的了解和使用意愿:一项研究。
PLoS One. 2024 Sep 11;19(9):e0307715. doi: 10.1371/journal.pone.0307715. eCollection 2024.
4
Onco-TESE (Testicular Sperm Extraction): Insights from a Tertiary Center and Comprehensive Literature Analysis.睾丸精子提取术(Onco-TESE):来自一个三级中心的见解和全面文献分析。
Medicina (Kaunas). 2023 Jun 29;59(7):1226. doi: 10.3390/medicina59071226.
5
Male infertility and urological tumors: Pathogenesis and therapeutical implications.男性不育与泌尿生殖系统肿瘤:发病机制与治疗学意义。
Urologia. 2023 Nov;90(4):622-630. doi: 10.1177/03915603221146147. Epub 2023 Jul 25.
6
A retrospective study on sperm cryopreservation in 1034 patients diagnosed with cancer in southern China.在中国南方诊断患有癌症的 1034 例患者的精子冷冻保存回顾性研究。
Asian J Androl. 2023;25(4):499-504. doi: 10.4103/aja202289.
7
The importance of the urologist in male oncology fertility preservation.泌尿科医师在男性肿瘤患者生育力保存中的重要性。
BJU Int. 2022 Nov;130(5):637-645. doi: 10.1111/bju.15772. Epub 2022 May 31.
8
Semen quality from patients affected by seminomatous and non-seminomatous testicular tumor.精原细胞瘤和非精原细胞瘤睾丸肿瘤患者的精液质量。
Int Braz J Urol. 2021 May-Jun;47(3):495-502. doi: 10.1590/S1677-5538.IBJU.2021.99.01.
9
Fertility considerations in men with testicular cancer.睾丸癌男性的生育相关考量
Transl Androl Urol. 2020 Jan;9(Suppl 1):S14-S23. doi: 10.21037/tau.2019.08.08.
10
Aberrant expression of sperm‑specific glycolytic enzymes are associated with poor sperm quality.精子特异性糖酵解酶的异常表达与精子质量差有关。
Mol Med Rep. 2019 Apr;19(4):2471-2478. doi: 10.3892/mmr.2019.9926. Epub 2019 Feb 1.